Cerora Inc.

116 Research Drive Suite 2207
Bethlehem, PA 18015 USA
Click for website

Research Sector Healthcare IT; Medical Devices

Summary Description Healthcare IT, device & software platform for brain injury detection and assessment

Management Adam J Simon-President/CEO; David M Devilbiss-Head R&D; Gary Kath-Head Engineering; Jim Sullivan-Head Sales; Denis Goldenberg-Head Marketing; Gloria Ferko-Head of Quality and Regulatory Affairs

Click here for Financial Data
Keywords: Healthcare IT, Medic Device Diagnostics, concussion, mild Traumatic Brain Injury, Alzheimer's disease, Autism, Parkinson's disease, brain health, psychiatry, neurology, diagnostic


Updated: Oct. 21, 2015


Cerora Inc. is a brain biosensor information company developing and commercializing affordable, accessible neurodiagnostic information for brain health assessment generally and concussion specifically......view more

Products / Services

Cerora will sell non-invasive electronic neuro diagnostic medical devices to be used in combination with mobile applications running on laptops, tablet computers and smart phones. The Company's produc......view more

Technology / Differentiation

Involves the use of objective biosensors to collect, transfer, analyze and present neurodiagnostic information to aid in the diagnosis and management of concussion and other neurological and psychiatr...view more

Market / Customers

Concussion and Alzheimer's disease (AD) are subjective clinical diagnoses in dire need of objective diagnostic tests. In concussion, incidence estimates range up to 3.8 million traumatic brain injurie......view more

Competitors / Substitutes / Alternatives

Cerora direct competition includes Cognistat, CNS Vitals, Screen Inc, Cambridge Cognition, ImPACT, CogState, Axon Sports, NeuroVigil, BrainScope, Brain Fx, X2 Biosystems & Neuronetrix. Indirect modal...view more

Revenue / Funding

Not disclosed at this time....view more


Presently selling biomarker services to pharma, biotech and med tech companies (first paying customer). 10 IRB approved clinical protocols, over 1000 scans to date, over 60 TBI's scanned, 2 positive c...view more

Analyst Coverage